drugset / Trial / NCT03336437

Estrogen and the Urogenital Microbiome in GSM

NCT03336437

Phase 4 Completed 40 enrolled Oregon Health and Science University
RandomizedParallel-groupSingle-blindBasic science

Summary

This is a study of how local estrogen treatment affects the microbiome of the vagina and bladder in postmenopausal women experiencing symptoms as part of "Genitourinary Syndrome of Menopause." The goal is to understand more about the underlying microbial changes occurring in menopause and whether these are reversible with estrogen.

Timeline

Start
2018-02-01
Primary completion
2019-08-23
Completion
2019-08-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 2 mg Other

Indications

No indication recorded.